Krishna Saxena joined the SGC Frankfurt July 2020. Krishna studied Biochemistry in Frankfurt (Germany) followed by a PhD (1999) in heterologous expression of membrane proteins at the Institute of Biochemistry (Frankfurt). Then, he was leading a molecular biology and protein expression group for a collaboration between Aventis Research & Technologies and the Goethe University (1999-2001), later MRPharm (2001-2002), a biotechnology company spin out of Frankfurt University and shortly part of Affinium Pharmaceuticals. The focus of his work became structure-based drug discovery by NMR spectroscopy and X-ray diffraction. From 2003-2011, he was working as a group leader (collaboration Sanofi and Goethe University) to study the family of protein kinases and subsequently to investigate biomedically relevant protein-protein interactions (PPIs) with focus on the modulation of such interactions by low molecular weight ligands guided by NMR technology. Since 2012, he has worked in the drug development platform at the DKTK German Cancer Consortium and for several industrial collaborations.
Kim Y, Lučić A, Lenz C, Farges F, Schwalm MP, Saxena K, Hanke T, Marples PG, Aschenbrenner JC, Fearon D, von Delft F, Krämer A, Knapp S
Commun Chem. 2025-6-14 . 8(1):185 .doi: 10.1038/s42004-025-01574-3
PMID: 40514378Schwalm MP, Lenz C, Saxena K, Klionsky DJ, Proschak E, Knapp S
Autophagy. 2025-5-9 . 1-5 .doi: 10.1080/15548627.2025.2498506
PMID: 40344429Schwalm MP, Dopfer J, Kumar A, Greco FA, Bauer N, Löhr F, Heering J, Cano-Franco S, Lechner S, Hanke T, Jaser I, Morasch V, Lenz C, Fearon D, Marples PG, Tomlinson CWE, Brunello L, Saxena K, Adams NBP, von Delft F, Müller S, Stolz A, Proschak E, Kuster B, Knapp S, Rogov VV
Nat Commun. 2024-11-26 . 15(1):10204 .doi: 10.1038/s41467-024-54409-5
PMID: 39587067Gerninghaus J, Zhubi R, Krämer A, Karim M, Tran DHN, Joerger AC, Schreiber C, Berger LM, Berger BT, Ehret TAL, Elson L, Lenz C, Saxena K, Müller S, Einav S, Knapp S, Hanke T
J Med Chem. 2024-7-19 . .doi: 10.1021/acs.jmedchem.4c00411
PMID: 39028937Muñoz Sosa CJ, Lenz C, Hamann A, Farges F, Dopfer J, Krämer A, Cherkashyna V, Tarnovskiy A, Moroz YS, Proschak E, Němec V, Müller S, Saxena K, Knapp S
ACS Chem Biol. 2024-6-27 . .doi: 10.1021/acschembio.4c00301
PMID: 38934237Schwalm MP, Saxena K, Müller S, Knapp S
Nat Protoc. 2024-4-18 . .doi: 10.1038/s41596-024-00979-z
PMID: 38637703Gerninghaus J, Zhubi R, Kraemer A, Karim M, Tran DHN, Joerger AC, Schreiber C, Berger LM, Berger BT, Ehret TAL, Elson L, Lenz C, Saxena K, Mueller S, Einav S, Knapp S, Hanke T
bioRxiv. 2024-2-18 . .doi: 10.1101/2024.02.18.580805
PMID: 38405908Schwalm MP, Krämer A, Dölle A, Weckesser J, Yu X, Jin J, Saxena K, Knapp S
Cell Chem Biol. 2023-6-20 . .doi: 10.1016/j.chembiol.2023.06.002
PMID: 37354907Hargittay B, Mineev KS, Richter C, Sreeramulu S, Jonker HRA, Saxena K, Schwalbe H
Biomol NMR Assign. 2023-4-29 . .doi: 10.1007/s12104-023-10132-8
PMID: 37118562Schwalm MP, Berger LM, Meuter MN, Vasta JD, Corona CR, Röhm S, Berger BT, Farges F, Beinert SM, Preuss F, Morasch V, Rogov VV, Mathea S, Saxena K, Robers MB, Müller S, Knapp S
Front Cell Dev Biol. 2022-6-21 . 10:886537 .doi: 10.3389/fcell.2022.886537
PMID: 35721509